Guideline on allergen-speci c immunotherapy in IgE-mediated allergic diseases

O L I V E R PFA A R1, 2, CL AUS BAC H E R T3, AL B R E C H T BU FE 4, RO L A N D BU H L 5, CH R IS TO F EB N E R 6, PE T E R EN G7, FR A N K FR I E D R I C HS 8, TH O M A S FU C HS 9, EC K A R D HA M E L M A N N10, DO R IS HA R T W I G-BA D E11, TH O M A S HE R I N G12, IS I D O R HU T T E G G E R13, K I R S T E N JU N G14, LU D G E R K L I M E K1, MAT T H I A S VO L K M A R KO PP15, HA NS ME R K16, UTA R A B E17, JOAC H I M SA LO G A18, PE T E R SC H M I D -G R E N D E L M E I E R19, AN TJ E SC H US T E R 20, NI CO L AUS SC H W E R K 21, HE L M U T SI T T E R 22, UL R I C H UM PFE N BAC H 23, BE T T I N A WE D I24, ST E FA N WÖ H R L 25, MA R G I T TA WO R M 26, JÖ R G K L E I N E-TE B B E 27 CO M M E N T I N G PA R T I C I PA N T S A N D FAC I L I TATO R S: SUSA N N E K AU L 28, AN JA SC H WA L FE N B E R G 29